Solid cancer incidence in atomic bomb survivors exposed in utero or as young children

Journal of the National Cancer Institute

Volumn 100, Issue 6, 2008, Pages 428-436

  Preston, Dale L ^a   Cullings, Harry ^b   Suyama, Akihiko ^c   Funamoto, Sachiyo ^b   Nishi, Nobuo ^b   Soda, Midori ^c   Mabuchi, Kiyohiko ^d   Kodama, Kazunori ^c   Kasagi, Fumiyoshi ^b   Shore, Roy E ^c  

^a Hirosoft International Corporation   (United States)

^b Department of Statistics ^*  (Japan)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATOMIC BOMB SURVIVOR; CANCER INCIDENCE; CANCER RISK; CHILD; CHILDHOOD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POISSON DISTRIBUTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RISK ASSESSMENT; SOLID TUMOR; STATISTICAL ANALYSIS; AGE; ATOMIC BOMB; COHORT ANALYSIS; FETUS; FOLLOW UP; INCIDENCE; INFANT; MATHEMATICAL COMPUTING; MIDDLE AGED; NEOPLASM; NEWBORN; PREGNANCY; PRESCHOOL CHILD; RADIATION EXPOSURE; RADIATION RESPONSE; REGISTER; RISK; RISK FACTOR; SAMPLE SIZE; STATISTICS; SURVIVOR;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FETUS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; JAPAN; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; NEOPLASMS; NUCLEAR WEAPONS; ODDS RATIO; POISSON DISTRIBUTION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGISTRIES; RISK FACTORS; SAMPLE SIZE; SURVIVORS;

EID: 41449112583     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn045     Document Type: Article

References (48)

1. Kato H, Keehn RJ. Mortality in live born children who were in-utero at the time of the atomic bombs (ABCC TR 13-66). Hiroshima, Japan: Atomic Bomb Casualty Commission; 1966.
2. Jablon S, Kato H. Childhood cancer in relation to prenatal exposure to atomic-bomb radiation. Lancet. 1970;2(681):1000-1003.
3. Kato H. Mortality in children exposed to the A-bombs while in utero, 1945-1969. Am J Epidemiol. 1971;93(6):435-442.
4. Ishimaru T, Ichimaru M, Mikami M. Leukemia incidence among individuals exposed in utero, children of atomic bomb survivors, and their controls; Hiroshima and Nagasaki (RERF TR 11-81). Hiroshima, Japan: Radiation Effects Research Foundation; 1981.
5. Yoshimoto Y, Kato H, Schull WJ. Risk of cancer among children exposed in utero to A-bomb radiations, 1950-84. Lancet. 1988;2(8612):665-669.
6. Yoshimoto Y, Delongchamp R, Mabuchi K. In-utero exposed atomic bomb survivors: cancer risk update. Lancet. 1994;344(8918):345-346.
7. Delongchamp RR, Mabuchi K, Yoshimoto Y, Preston DL. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992. Radiat Res. 1997;147(3):385-395.
8. Preston DL, Pierce DA, Shimizu Y, et al. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res. 2004;162(4):377-389.
9. Young RW, Kerr GD, eds. Reassessment of the Atomic-Bomb Radiation Dosimetry for Hiroshima and Nagasaki: Dosimetry System 2002. Hiroshima, Japan: Radiation Effects Research Foundation; 2005.
10. Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. Dose estimation for atomic bomb survivor studies: its evolution and present status. Radiat Res. 2006;166(1):219-254.
11. Fujita S. Versions of DS86. RERF Update. 1989;1(2):2-3.
12. Kerr GD. Organ dose estimates for the Japanese atomic-bomb survivors. Health Phys. 1979;37(4):487-508.
13. Hashizume T, Maruyama T, Nishizawa K, Nishimura A. Dose estimation of human fetus exposed in utero to radiation from atomic bombs in Hiroshima and Nagasaki. J Radiat Res. 1973;14(4):346-362.
14. Cologne JB, Preston DL. Longevity of atomic-bomb survivors. Lancet. 2000;356(9226):303-307.
15. Mabuchi K, Soda M, Ron E, et al. Cancer incidence in atomic bomb survivors. Part I: use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res. 1994;137(2 suppl):S1-S16.
16. Beebe G, Usagawa M. The Major ABCC Samples. Hiroshima, Japan: Radiation Effects Research Foundation (RERF TR 12-68); 1968.
17. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality:1950-1997. Radiat Res. 2003;160(4):381-407.
18. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res. 1994;137(2 suppl):S17-S67.
19. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70(830):130-139.
20. Sposto R, Preston DL. Correcting for catchment area nonresidency in studies based on tumor registry data. Hiroshima, Japan: Radiation Effects Research Foundation; 1992(RERF CR 1-92).
21. Imaizumi M, Usa T, Tominaga T, et al. Long-term prognosis of thyroid nodule cases compared with nodule-free controls in atomic bomb survivors. J Clin Endocrinol Metab. 2005;90(9):5009-5014.
22. Yamada M, Kodama K, Fujita S, et al. Prevalence of skin neoplasms among the atomic bomb survivors. Radiat Res. 1996;146(2):223-226.
23. Fritz AG, Percy C, Jack A, Sobin LH, Parkin MD. International classification of diseases for oncology (ICD-O-3). 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
24. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155. Lyon, France: IARC; 2002.
25. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors:1958-1998. Radiat Res. 2007;168(1):1-64.
26. Breslow N, Day N. Statistical Methods in Cancer Research Vol 2. The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1988.
27. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure Users Guide. Seattle, WA: Hirosoft International Corporation; 1993.
28. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res. 1990;123(3):275-284.
29. Pierce DA, Preston DL, Stram DO, Vaeth M. Allowing for dose-estimation errors for the A-bomb survivor data. J Radiat Res. 1991;32 suppl:108-121.
30. Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res. 2000;154(2):178-186.
31. Cox DR, Hinckley DV. Theoretical Statistics. New York: Chapman Hall; 1974.
32. Ostroumova E, Akleyev A, Hall P. Infant mortality among offspring of individuals living in the radioactively contaminated Techa River area, southern Urals. Acta Medica Nagasakiensia. 2005;50(1):23-28.
33. Ohtaki K, Kodama Y, Nakano M, et al. Human fetuses do not register chromosome damage inflicted by radiation exposure in lymphoid precursor cells except for a small but significant effect at low doses. Radiat Res. 2004;161(4):373-379.
34. Nakano M, Kodama Y, Ohtaki K, et al. Chromosome aberrations do not persist in the lymphocytes or bone marrow cells of mice irradiated in utero or soon after birth. Radiat Res. 2007;167(6):693-702.
35. Inano H, Suzuki K, Onoda M, Yamanouchi H. Susceptibility of fetal, virgin, pregnant and lactating rats for the induction of mammary tumors by gamma rays. 1996;145(6):708-713.
36. Di Majo V, Coppola M, Rebessi S, Covelli V. Age-related susceptibility of mouse liver to induction of tumors by neutrons. Radiat Res. 1990;123(2):227-234.
37. Benjamin SA, Lee AC, Angleton GM, Saunders WJ, Keefe TJ, Mallinckrodt CH. Mortality in beagles irradiated during prenatal and postnatal development. II. Contribution of benign and malignant neoplasia. Radiat Res. 1998;150(3):330-348.
38. Di Majo V, Rebessi S, Pazzaglia S, Saran A, Covelli V. Carcinogenesis in laboratory mice after low doses of ionizing radiation. Radiat Res. 2003;159(1):102-108.
39. Schmahl W. Synergistic induction of tumours in NMRI mice by combined foetal X-irradiation with low doses and ethylnitrosourea administered to juvenile offspring. Carcinogenesis. 1988;9(8):1493-1498.
40. Seed TM, Kaspar LV, Tolle DV, Fritz TE. Chronic radiation leukemogenesis: postnatal hematopathologic effects resulting from in-utero irradiation. Leuk Res. 1987;11(2):171-179.
41. Sasaki K, Kasuga T. Life-shortening and carcinogenesis in mice irradiated at the prenatal period with gamma rays. In: Thompson RC, Mahaffey JA, eds. Life-Span Radiation Effects Studies in Animals: What Can They Tell Us?(CONF-830951). Washington, DC: Office of Scientific Information and Technology, Department of Energy; 1986.
42. Schmahl W. Long-term effects after prenatal irradiation. In: Streffer C, Patrick G, eds. Effects of Prenatal Irradiation With Special Emphasis on Late Effects. Luxembourg: Commission of the European Communities; 1984.
43. Upton AC, Odell TT Jr, Sniffen EP. Influence of age at time of irradiation on induction of leukemia and ovarian tumors in RF mice. Proc Soc Exp Biol Med. 1960;104(5):769-772.
44. Ellender M, Harrison JD, Kozlowski R, Szluinska M, Bouffler SD, Cox R. In utero and neonatal sensitivity of ApcMin/+ mice to radiation-induced intestinal neoplasia. Int J Radiat Biol. 2006;82(3):141-151.
45. International Commission on Radiological Protection. ICRP publication 84: pregnancy and medical radiation. Ann ICRP. 2000;30(1):1-43.
46. Cousins C. Radiation and pregnancy. Advances in Radiation Protection in Medicine. Bethesda, MD: National Council on Radiation Protection and Measurements; 2007. www.ncrponline.org/Annual_Mtgs/2007_Ann_Meet_Prog.pdf. Accessed February 19, 2008.
47. Boice JD Jr, Miller RW. Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology. 1999;59(4):227-233.
48. International Commission on Radiological Protection. ICRP publication 90: Biological effects after prenatal irradiation(embryo and fetus). Ann ICRP. 2003;31(1-2):1-200.